【
Abstract
】
This paper uses the method of empirical analysis to conduct descriptive statistical and correlation tests on the data of pharmaceutical listed companies that implement equity incentives from 2016 to 2020, establishes a multiple regression analysis model, and conducts robustness tests, and finally concludes that: (1)
the
proportion of equity incentives of pharmaceutical listed companies is positively correlated with corporate performance, and (2) the impact of restricted stock an
医药上市公司股权激励对企业绩效影响的实证研究-12132字.docx